MetLife Investment Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-29,134
| Closed | -$691K | – | 2892 |
|
|
2023
Q3 | $691K | Hold |
29,134
| – | – | 0.01% | 1434 |
|
|
2023
Q2 | $473K | Hold |
29,134
| – | – | ﹤0.01% | 1725 |
|
|
2023
Q1 | $507K | Hold |
29,134
| – | – | ﹤0.01% | 1630 |
|
|
2022
Q4 | $547K | Hold |
29,134
| – | – | ﹤0.01% | 1586 |
|
|
2022
Q3 | $516K | Hold |
29,134
| – | – | ﹤0.01% | 1613 |
|
|
2022
Q2 | $508K | Sell |
29,134
-3,590
| -11% | -$68.4K | ﹤0.01% | 1649 |
|
|
2022
Q1 | $684K | Buy |
32,724
+10,823
| +49% | +$207K | ﹤0.01% | 1579 |
|
|
2021
Q4 | $390K | Hold |
21,901
| – | – | ﹤0.01% | 1638 |
|
|
2021
Q3 | $309K | Hold |
21,901
| – | – | ﹤0.01% | 1807 |
|
|
2021
Q2 | $363K | Hold |
21,901
| – | – | ﹤0.01% | 1767 |
|
|
2021
Q1 | $396K | Sell |
21,901
-2,913
| -12% | -$57.5K | ﹤0.01% | 1658 |
|
|
2020
Q4 | $453K | Hold |
24,814
| – | – | ﹤0.01% | 1532 |
|
|
2020
Q3 | $316K | Hold |
24,814
| – | – | ﹤0.01% | 1600 |
|
|
2020
Q2 | $272K | Hold |
24,814
| – | – | ﹤0.01% | 1714 |
|
|
2020
Q1 | $259K | Hold |
24,814
| – | – | ﹤0.01% | 1555 |
|
|
2019
Q4 | $399K | Hold |
24,814
| – | – | ﹤0.01% | 1582 |
|
|
2019
Q3 | $389K | Hold |
24,814
| – | – | ﹤0.01% | 1559 |
|
|
2019
Q2 | $494K | Hold |
24,814
| – | – | 0.01% | 1489 |
|
|
2019
Q1 | $418K | Hold |
24,814
| – | – | ﹤0.01% | 1571 |
|
|
2018
Q4 | $376K | Hold |
24,814
| – | – | ﹤0.01% | 1537 |
|
|
2018
Q3 | $498K | Hold |
24,814
| – | – | 0.01% | 1552 |
|
|
2018
Q2 | $484K | Hold |
24,814
| – | – | 0.01% | 1421 |
|
|
2018
Q1 | $339K | Hold |
24,814
| – | – | ﹤0.01% | 1618 |
|
|
2017
Q4 | $337K | Buy |
+24,814
| New | +$356K | ﹤0.01% | 1640 |
|
Other funds holding NXGN
MetLife Investment Management's NXGN Position: Q4 2023 in Review
MetLife Investment Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 29,134 shares — an estimated $691K sold.
MetLife Investment Management first reported a position in NXGN in Q4 2017 and held it in 24 quarters. The position peaked at $691K in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- MetLife Investment Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- MetLife Investment Management sold 29,134 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $691K.
- MetLife Investment Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2017 and held it in 24 quarters.
- MetLife Investment Management's NextGen Healthcare, Inc. Common Stock position peaked at $691K in Q3 2023.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.